series-c-plus
Stage
2018
Founded
3
Investors
About
NewAmsterdam Pharma is a Netherlands-based biotechnology company headquartered in Naarden that develops orally administered therapies for metabolic and lipid-related conditions, including treatments for cardiovascular disease. The company is incorporated in the Netherlands and trades on NASDAQ under the ticker NAMS.
Explore NewAmsterdam Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.